Accès ouvert · CC BY

Is the development of liquid biopsy for the early detection and the monitoring of breast cancers on its way of overtaking mammography?

Article scientifique 2024 Sciences de la santé Anglais

Résumé

Mammography, as of today, is used as a gold standard for screening, diagnosing, and monitoring breast cancer (BC). While overall beneficial, it presents several downsides, such as limitations in accuracy, relatively high costs, and dependence on heavy infrastructure, greatly limiting accessibility for the entire global target population. There is currently no established alternative to mammography, and overcoming this major challenge is a hot topic in research and technology. One avenue for tackling this issue is the development of highly sensitive and specific non-invasive blood tests for the early diagnosis and follow-up of breast cancer. This paper discusses the limitations of mammography and recapitulates the blood tests already available, those under development, and future developments in this field.

Citer ce document

Mansour, H., Nejjari, C., Incitti, R., Anouar, N., & Ouhajjou, A. (2024). Is the development of liquid biopsy for the early detection and the monitoring of breast cancers on its way of overtaking mammography?. Frontiers in Medicine. https://doi.org/10.3389/fmed.2024.1415940

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 28/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 9

Téléchargements (hors robots) : 0

Méthode de comptage